Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| Age-Related Macular Degeneration Quality of Life Scale× | National Eye Institute Visual Function Questionnaire-25× | |
|---|---|---|
| Valdkond | Oftalmoloogia | Oftalmoloogia |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta≠ | 2005 | 2001 |
| Looja≠ | Mitchell J, Bradley C et al. | Mangione CM, Lee PP et al. |
| Tüüp | Self-report | Self-report |
| Algallikas≠ | Mitchell, J., Bradley, C., Anderson, S. J., et al. (2005). Perceived impact of retinal impairment on quality of life: the AMD and Cataract Symptom Effect Questionnaire. Health Qual Life Outcomes, 3(1), 12. DOI ↗ | Mangione, C. M., Lee, P. P., Gutierrez, P. R., et al. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol, 119(7), 1050-1058. DOI ↗ |
| Rööpnimetused≠ | AMD-QoL, Macular QoL | VFQ-25 |
| Seotud | 4 | 4 |
| Kokkuvõte≠ | The AMD Quality of Life (AMD-QoL) scale is a disease-specific instrument designed to measure the impact of age-related macular degeneration on patient-reported health-related quality of life. Developed by Mitchell, Bradley, and colleagues (2005), the AMD-QoL addresses concerns unique to macular disease: central vision loss, reading difficulty, facial recognition, driving impairment, and emotional burden. It serves as a primary or secondary outcome in AMD clinical trials and informs patient-centered care decisions. | The NEI-VFQ-25 is a 25-item self-report questionnaire measuring the impact of vision loss on health-related quality of life across multiple functional and psychological domains. Developed by the National Eye Institute (Mangione et al., 2001), it is the most widely used vision-specific QoL instrument in ophthalmology and serves as the gold standard for quantifying patient-reported visual disability across diverse eye conditions. |
| ScholarGateAndmestik ↗ |
|
|